Pharma Focus Asia
MasterControl - Avoid Falling Behind the Pharma Market

Novel HER2-Targeted Bispecific Antibody Zanidatamab Developed for Patients with Biliary Tract Cancer

Zanidatamab, a bispecific antibody developed for the treatment of patients with previously-treated HER2 gene-amplified Biliary Tract Cancer (BTC).

Zanidatamab is built on Zymeworks’ Azymetric™ platform binding two non-overlapping epitopes of HER2 known asbiparatopic binding. This results in numerous mechanisms of action including twin HER2 signal blockade, increased binding and removal of HER2 protein from the cell surface, and potent effector function which leads to the encouragement of antitumor activity in patients.

Biliary Tract Cancer (BTC), such as gallbladder cancer and cholangiocarcinoma (bile duct cancer), is related with poor prognosis accounting for 3 per cent of all adult cancers.

Worldwide, more than 210,000 people are diagnosed with Biliary tract cancer (BTC) annually. Moreover patients (>65%) affected with BTC are diagnosed with tumors which cannot be removed by surgically. Inspite of patients undergoing curative surgery, BTC cannot be cured permanently and has a high recurrence rate. Patients with advanced BTC have very few treatment options after experiencing front-line chemotherapy.

HER2 is a well targeted anti-cancer therapy. Tumor cells producing HER2 higher than normal level will grow more quickly and spread to other parts of the body.

U.S. Food and Drug administrator has granted breakthrough therapy designation for HER2-Targeted Bispecific Antibody Zanidatamab in Patients with Biliary Tract Cancer.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Increasing the likelihood of your drug approvalMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® productsMedical Fair Thailand 20235th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023
MasterControl - 6 Essential Features in an eQMS